Mostrando 5 resultados de: 5
Filtros aplicados
Coating an adenovirus with functionalized gold nanoparticles favors uptake, intracellular trafficking and anti-cancer therapeutic efficacy
ArticleAbstract: Adenoviral (Ad) vectors have proven to be important tools for gene and cell therapy, although some iPalabras claves:Adenovirus, Cancer gene therapy, Gold nanoparticles, hNIS, Mesenchymal stem cellsAutores:De La Fuente J.M., de Martino A., Gimeno M., Hallden G., Hernandez Y., Man Y.K.S., Martin‐duque P., Quintanilla M., REBECA GONZALEZ-PASTORFuentes:googlescopusComplexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models
ArticleAbstract: Oncolytic adenoviruses (OAd) can be employed to efficiently eliminate cancer cells through multiplePalabras claves:AuNP, oncolytic adenovirus, PCa, PDAC, tumour-selectiveAutores:Aguirre-Hernandez C., Fernandez A., Hallden G., Man Y.K.S., Martin‐duque P., REBECA GONZALEZ-PASTORFuentes:googlescopusDefining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
ArticleAbstract: Background: Virotherapy represents a promising approach for ovarian cancer. In this regard, conditioPalabras claves:Adenovirus, Anti-tumor immunization, CRAd, ID8, Ovarian Cancer, VirotherapyAutores:Ashshi A.M., Curiel D.T., Dmitriev I.P., El-Shemi A.G., Goedegebuure S.P., Kashentseva E.A., Lu Z.H., Podhajcer O.L., REBECA GONZALEZ-PASTORFuentes:googlescopusUnderstanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
ReviewAbstract: Ovarian cancer is the leading cause of death among women with gynecological cancer, with an overallPalabras claves:Autores:Curiel D.T., Goedegebuure S.P., REBECA GONZALEZ-PASTORFuentes:googlescopusViral and Nonviral Vectors for In Vivo and Ex Vivo Gene Therapies
Book PartAbstract: Gene therapy is the therapeutic delivery of nucleic acids for treatment of genetic diseases into patPalabras claves:clinical trials, exosomes, Gene therapy, Nonviral vectors, viral vectorsAutores:Crespo-Barreda A., Encabo-Berzosa M.M., Iglesias M., Martin‐duque P., Ortíz-Teba P., REBECA GONZALEZ-PASTOR, Serrano J.L.Fuentes:googlescopus